Estimating selected screening-related parameters using New Zealand–specific glaucoma prevalence data: optometry visits for glaucoma screening at age 45 years

background: Regular eye examinations for glaucoma at age 45 years and every 5 years after have been promoted in the New Zealand setting. We aimed to estimate selected screening-related parameters for optometry visits for glaucoma screening at age 45 years. methods: Selected glaucoma screening parameters were identified from the literature, and data were extracted from a New Zealand longitudinal study (Dunedin Study) on the prevalence of glaucoma in 45-year-olds. Out-of-pocket costs were estimated from New Zealand optometry assessment fees. results: We estimate that routine screening for glaucoma within a New Zealand cohort of 45-year-olds has a low positive predictive value of 5.4%. That is, for every 100 people who get a positive screening result for glaucoma, around 95 of these diagnoses would be expected to be false positives and only five would truly have glaucoma. The number needed to screen to detect one case of glaucoma was estimated at 177. The out-of-pocket cost per true case of glaucoma detected was around NZ$24,300, equivalent to NZ$5.8 million at the national level to detect 241 true cases per year (assuming 70% uptake). However, there would be many other additional costs likely with any formal screening programme encompassing the full clinical pathway. conclusion: These New Zealand–specific findings for selected screening parameters align with recommendations from international agencies showing that there is a lack of evidence in favour of population screening for glaucoma. Future research could focus on evaluating more targeted screening or risk-based screening, e.g., using artificial intelligence–assisted fundus imaging.

Authors

Publication Details

Journal
New Zealand Medical Journal
Published
2026-11-20
DOI
https://doi.org/10.26635/6965.7590
Primary Topic
Glaucoma and retinal disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Estimating selected screening-related parameters using New Zealand–specific glaucoma prevalence data: optometry visits for glaucoma screening at age 45 years

Nick Wilson, Graham Wilson
1 links
New Zealand Medical Journal
Glaucoma and retinal disorders
article

Estimating selected screening-related parameters using New Zealand–specific glaucoma prevalence data: optometry visits for glaucoma screening at age 45 years

Nick Wilson, Graham Wilson
article en

Abstract

background: Regular eye examinations for glaucoma at age 45 years and every 5 years after have been promoted in the New Zealand setting. We aimed to estimate selected screening-related parameters for optometry visits for glaucoma screening at age 45 years. methods: Selected glaucoma screening parameters were identified from the literature, and data were extracted from a New Zealand longitudinal study (Dunedin Study) on the prevalence of glaucoma in 45-year-olds. Out-of-pocket costs were estimated from New Zealand optometry assessment fees. results: We estimate that routine screening for glaucoma within a New Zealand cohort of 45-year-olds has a low positive predictive value of 5.4%. That is, for every 100 people who get a positive screening result for glaucoma, around 95 of these diagnoses would be expected to be false positives and only five would truly have glaucoma. The number needed to screen to detect one case of glaucoma was estimated at 177. The out-of-pocket cost per true case of glaucoma detected was around NZ$24,300, equivalent to NZ$5.8 million at the national level to detect 241 true cases per year (assuming 70% uptake). However, there would be many other additional costs likely with any formal screening programme encompassing the full clinical pathway. conclusion: These New Zealand–specific findings for selected screening parameters align with recommendations from international agencies showing that there is a lack of evidence in favour of population screening for glaucoma. Future research could focus on evaluating more targeted screening or risk-based screening, e.g., using artificial intelligence–assisted fundus imaging.

New Zealand Medical JournalVol. 139(1646)
Good health and well-being
Glaucoma and retinal disorders
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon